Iwai S, Kaji K, Nishimura N, Kubo T, Tomooka F, Shibamoto A, Suzuki J, Tsuji Y, Fujinaga Y, Kitagawa K, Namisaki T, Akahane T, Yoshiji H
Results show that the 25 mg dose of Rybelsus can lead to weight loss similar to Wegovy, which is specifically approved for weight management
- TRIUMPH-2: Weight management basket trial in adults with T2D, with nested OSA and OA protocols
The frequency of B-12 injections depends on the severity of the deficiency and individual health needs
These findings suggest potential neuroprotective benefits of semaglutide, especially regarding cognitive health, and call for further research to validate its use in treating cognitive deficits and substance misuse in patients with T2DM (87)
With strong worldwide operations and a wide-ranging healthcare portfolio behind it, Novo Nordisk holds a clear leadership position in the GLP-1 agonists market